Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,754 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04169399 | Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT | unknown | Phase 2 | 30 | Sun Yat-sen UniversityOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT04161560 | Cetuximab - IRDye800 Intraoperative Fluorescence Imaging in Esophagectomy of Esophageal Cancer | unknown | Phase 1 | 40 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Nov 13, 2019 | clinicaltrials |
| NCT04028778 | Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC(FL-ALTER) | unknown | Phase 3 | 310 | Sun Yat-sen UniversityOTHER | 1 | Nov 8, 2019 | clinicaltrials |
| NCT04157491 | Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer | unknown | Phase 1 / Phase 2 | 23 | Sun Yat-sen UniversityOTHER | 1 | Nov 8, 2019 | clinicaltrials |
| NCT04136886 | Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma(IMRT) | recruiting | Phase 3 | 346 | Sun Yat-sen UniversityOTHER | 1 | Oct 23, 2019 | clinicaltrials |
| NCT00844454 | Multi-pronged Ethanol Ablation and Radiofrequency Ablation of Early-stage Hepatocellular Carcinoma(QPEAvsRFA) | completed | N/A | 81 | Sun Yat-sen UniversityOTHER | 1 | Oct 8, 2019 | clinicaltrials |
| NCT04108338 | Prospective Comparisons of Clinical Trial and Real-world Outcomes in Nasopharyngeal Carcinoma | completed | — | 5,448 | Sun Yat-sen UniversityOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT03925896 | Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients | unknown | Phase 1 | 27 | Sun Yat-sen UniversityOTHER | 1 | Sep 12, 2019 | clinicaltrials |
| NCT04086888 | Real World Study of Immune Checkpoint Inhibitors for Advanced Gastric Cancer | unknown | — | 170 | Sun Yat-sen UniversityOTHER | 1 | Sep 12, 2019 | clinicaltrials |
| NCT02961998 | Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail | completed | Phase 4 | 116 | Sun Yat-sen UniversityOTHER | 0 | Sep 10, 2019 | clinicaltrials |
| NCT04053725 | Prediction of the Efficacy of ctDNA in Immunotherapy for Advanced Gastric Cancer | unknown | — | 200 | Sun Yat-sen UniversityOTHER | 1 | Sep 9, 2019 | clinicaltrials |
| NCT04074447 | The Efficacy of Immunodetection Point Inhibitors for Advanced Esophageal Cancer | unknown | — | 80 | Sun Yat-sen UniversityOTHER | 1 | Sep 9, 2019 | clinicaltrials |
| NCT02789189 | Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail | terminated | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 0 | Sep 6, 2019 | clinicaltrials |
| NCT02648802 | Cavity Shaving in Breast Conserving Surgery for Breast Cancer Patients | completed | N/A | 181 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 22, 2019 | clinicaltrials |
| NCT03181815 | Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia | unknown | Phase 2 | 48 | Sun Yat-sen UniversityOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT03318419 | Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic Leukemia | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT03905967 | TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC(TACE) | unknown | Phase 3 | 336 | Sun Yat-sen UniversityOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT03939975 | Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCC | completed | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT04003558 | Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01) | unknown | — | 1,500 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 15, 2019 | clinicaltrials |
| NCT03059238 | Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure | completed | Phase 3 | 213 | Sun Yat-sen UniversityOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT04053972 | The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | unknown | Phase 3 | 377 | Sun Yat-sen UniversityOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT04053985 | The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 3 | 206 | Sun Yat-sen UniversityOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT03020329 | Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 37 | Sun Yat-sen UniversityOTHER | 1 | Aug 7, 2019 | clinicaltrials |
| NCT04021992 | GVD±R Regimen for ASCT-eligible Patients With Refractory/Relapsed DLBCL | unknown | Phase 2 | 48 | Sun Yat-sen UniversityOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT00806117 | Comparison of Different Subsequent Treatments After Radical Surgery(STARS) | unknown | Phase 3 | 1,080 | Sun Yat-sen UniversityOTHER | 1 | Jul 30, 2019 | clinicaltrials |
| NCT04034823 | KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast Cancer | unknown | Phase 2 | 59 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jul 26, 2019 | clinicaltrials |
| NCT04023292 | Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer | unknown | Phase 2 | 185 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 17, 2019 | clinicaltrials |
| NCT04023448 | The Effect of Different Reconstruction Methods on Anterior Resection Syndrome(TEDRMARS) | unknown | N/A | 138 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jul 17, 2019 | clinicaltrials |
| NCT03830385 | Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck | unknown | Phase 2 | 51 | Sun Yat-sen UniversityOTHER | 1 | Jul 16, 2019 | clinicaltrials |
| NCT01570166 | Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma | unknown | N/A | 210 | Sun Yat-sen UniversityOTHER | 1 | Jun 26, 2019 | clinicaltrials |
| NCT03997539 | A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 | 256 | Sun Yat-sen UniversityOTHER | 0 | Jun 25, 2019 | clinicaltrials |
| NCT03993964 | Study to Evaluate the Efficacy and Safety of CDK4/6 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast Cancer | unknown | Phase 2 | 20 | Sun Yat-sen UniversityOTHER | 0 | Jun 21, 2019 | clinicaltrials |
| NCT02958111 | Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma(CAN) | unknown | Phase 3 | 406 | Sun Yat-sen UniversityOTHER | 1 | Jun 12, 2019 | clinicaltrials |
| NCT03129854 | Androgen Deprivation Therapy (ADT) Versus ADT Plus Prostate Cryotherapy for Metastatic Prostate Cancer (mPCa) | unknown | N/A | 250 | Sun Yat-sen UniversityOTHER | 1 | Jun 7, 2019 | clinicaltrials |
| NCT02087475 | Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin | unknown | Phase 3 | 360 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Jun 5, 2019 | clinicaltrials |
| NCT03975049 | Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer | not yet recruiting | Phase 3 | 933 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 0 | Jun 5, 2019 | clinicaltrials |
| NCT03919383 | Phase II of Lenvatinib Plus Toripalimab for Advanced HCC | withdrawn | Phase 2 | 0 | Sun Yat-sen UniversityOTHER | 1 | Jun 3, 2019 | clinicaltrials |
| NCT03780634 | HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC | withdrawn | Phase 2 | 0 | Sun Yat-sen UniversityOTHER | 1 | May 6, 2019 | clinicaltrials |
| NCT03803254 | HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC | withdrawn | Phase 2 | 0 | Sun Yat-sen UniversityOTHER | 1 | May 6, 2019 | clinicaltrials |
| NCT03744247 | Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCC | withdrawn | Phase 3 | 0 | Sun Yat-sen UniversityOTHER | 1 | May 2, 2019 | clinicaltrials |
| NCT03782831 | TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC | withdrawn | Phase 2 | 0 | Sun Yat-sen UniversityOTHER | 1 | May 2, 2019 | clinicaltrials |
| NCT03791918 | Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria | withdrawn | Phase 3 | 0 | Sun Yat-sen UniversityOTHER | 1 | May 2, 2019 | clinicaltrials |
| NCT03928652 | Prognostic Biomarker for CRC(PROMOTE) | unknown | — | 1,050 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Apr 26, 2019 | clinicaltrials |
| NCT03923335 | The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal Cancer | not yet recruiting | — | 287 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Apr 22, 2019 | clinicaltrials |
| NCT03654534 | Oral Nutritional Supplements Compared With Standard Diet in Postoperative Gastric Cancer Patients With Adjuvant Chemotherapy | unknown | Phase 3 | 374 | Sun Yat-sen UniversityOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03746249 | Phase II of Lenvatinib Plus PD-1 Antibody for Advanced HCC | withdrawn | Phase 2 | 0 | Sun Yat-sen UniversityOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03812770 | Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC | unknown | Phase 2 | 150 | Sun Yat-sen UniversityOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03912857 | Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT02556593 | IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases | terminated | Phase 2 | 12 | Sun Yat-sen UniversityOTHER | 1 | Apr 12, 2019 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials